Interactions Between ORG9426 and Other Non-depolarizing Neuromuscular Blocking Agents in Rats in Vivo

Overview

Journal J Anesth

Specialty Anesthesiology

Date 1992 Jul 1

PMID 15278537

Authors

K Watanabe

Affiliations

Soon will be listed here.

Abstract

In this study, combined neuromuscular blocking effects of ORG9426 with other non-depolarizing neuromuscular blocking agents were investigated. About 20% steady state neuromuscular block was established by a continuous infusion of one of 6 neuromuscular blocking agents (ORG9426, vecuronium, pancuronium, pipecuronium, d-tubocurarine and metocurine). Then 1/7 of the ED50 of ORG9426 or one of other neuromuscular blocking agents was administered in a single injection, and the increase in the neuromuscular block was observed. The combined neuromuscular blocking effect of ORG9426 and d-tubocurarine or ORG9426 and metocurine was significantly ( P < 0.05) greater than that of each corresponding control (the combination of same neuromuscular blocking agent). The effect of d-tubocurarine was also potentiated by vecuronium, pancuronium and pipecuronium. These potentiations were not observed between ORG9426 and pancuronium, pipecuronium or vecuronium. Possible mechanisms of these synergistic interactions were discussed.

References

Mirakhur R, Gibson F, Ferres C . Vecuronium and d-tubocurarine combination: potentiation of effect. Anesth Analg. 1985; 64(7):711-4. View

Bowman W . Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg. 1980; 59(12):935-43. View

Pollard B, Jones R . Interactions between tubocurarine, pancuronium and alcuronium demonstrated in the rat phrenic nerve-hemidiaphragm preparation. Br J Anaesth. 1983; 55(11):1127-31. DOI: 10.1093/bja/55.11.1127. View

Sine S, Taylor P . Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J Biol Chem. 1981; 256(13):6692-9. View

Waud B, WAUD D . Interaction among agents that block end-plate depolarization competitively. Anesthesiology. 1985; 63(1):4-15. DOI: 10.1097/00000542-198507000-00002. View

SHANKS C . Dose-response curves for alcuronium and pancuronium alone and in combination. Anaesth Intensive Care. 1982; 10(3):248-51. DOI: 10.1177/0310057X8201000314. View

Waud B, WAUD D . Quantitative examination of the interaction of competitive neuromuscular blocking agents on the indirectly elicited muscle twitch. Anesthesiology. 1984; 61(4):420-7. DOI: 10.1097/00000542-198410000-00010. View

Lebowitz P, RAMSEY F, Savarese J, Ali H . Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine. Anesth Analg. 1980; 59(8):604-9. View

Foldes F, Nagashima H, Nguyen H, Schiller W, MASON M, Ohta Y . The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia. Anesthesiology. 1991; 75(2):191-6. DOI: 10.1097/00000542-199108000-00004. View

10.

Ferres C, Mirakhur R, Pandit S, Clarke R, Gibson F . Dose-response studies with pancuronium, vecuronium and their combination. Br J Clin Pharmacol. 1984; 18(6):947-50. PMC: 1463666. DOI: 10.1111/j.1365-2125.1984.tb02568.x. View

11.

Pandit S, Ferres C, Gibson F, Mirakhur R . Time course of action of combinations of vecuronium and pancuronium. Anaesthesia. 1986; 41(2):151-4. DOI: 10.1111/j.1365-2044.1986.tb13170.x. View